About: Tocilizumab for the treatment of severe coronavirus disease 2019

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Tocilizumab for the treatment of severe coronavirus disease 2019 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 May 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2020 (fr) artículu científicu espublizáu en mayu de 2020 (ast) scientific article published on 05 May 2020 (en) наукова стаття, опублікована 5 травня 2020 (uk)
publication date	wds:Q94530923-ED79FEE4-09B2-43AB-92B9-D25111D1D371
publication date	2020-05-05 00:00:00Z (xsd:dateTime)
author name string	wds:Q94530923-033DAE9D-5F0B-45EC-8A4A-E8BAF6AB1F13 wds:Q94530923-18F0B5D5-22E1-41B2-B2EB-F89893850807 wds:Q94530923-2EA9E34B-2AFD-46CF-9622-4506C64F4DFA wds:Q94530923-4387BC53-A637-40FF-8207-F24B8CEEE5B3 wds:Q94530923-6018A5AC-7E39-4112-8B72-B50F8A4357C1 wds:Q94530923-7B3CA46C-A284-42FF-8912-0D4ECACF2983 wds:Q94530923-A69F3D8F-74E3-4698-9C82-A96CE6FAE496 wds:Q94530923-DD741507-A7EF-44F1-A3CF-C0B404F0256B
author name string	Hussam A Alsoub Joanne N Daghfal Kinda Shukri Mohamed Aboukamar Mohamed Y Khatib Muna A Almaslamani Shiema Abdalla Tawheeda B H Ibrahim
rdfs:label	Tocilizumab for the treatment of severe coronavirus disease 2019 (en) Tocilizumab for the treatment of severe coronavirus disease 2019 (nl)
skos:prefLabel	Tocilizumab for the treatment of severe coronavirus disease 2019 (en) Tocilizumab for the treatment of severe coronavirus disease 2019 (nl)
name	Tocilizumab for the treatment of severe coronavirus disease 2019 (en) Tocilizumab for the treatment of severe coronavirus disease 2019 (nl)
author	wds:Q94530923-31E89667-B11B-4712-B50D-D132B9B40757 wds:Q94530923-9BE604CE-9628-466A-8A15-E220DB0660FF wds:Q94530923-A5F0AC9A-169C-4E7F-8AC3-FB44F956643E wds:Q94530923-FFE74CF5-93A1-4470-9B71-A696C6D0E953
author	Ali S. Omrani Mohammed Abu-Khattab Rand Alattar Shahd H Shaar
title	wds:Q94530923-31E2EE71-1EE3-47D8-8F22-69D6C0169154
title	Tocilizumab for the treatment of severe coronavirus disease 2019 (en)
instance of	wds:Q94530923-27856949-8AEA-4922-992B-41AE3DC33BBF
instance of	scholarly article
main subject	wds:Q94530923-0441C7D0-9424-4C7F-958F-979E09B7B28F wds:Q94530923-71E62D67-CFC0-4875-A0F0-AE1DDDB403D6 wds:Q94530923-A9AB294E-B62A-4EB3-BB7C-F46EC49AE2A9
main subject	Coronaviridae tocilizumab COVID-19 mortality
PubMed ID	wds:Q94530923-744F1C91-974C-454A-8A5F-E4211559BD35
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32369191
PubMed ID	32369191
published in	wds:Q94530923-55A17604-5EE2-455C-8473-EE4DF752AB6C
published in	Journal of Medical Virology
DOI	wds:Q94530923-FF8DB11C-C70E-499D-AA9F-7110991ABFF4
DOI	http://dx.doi.org/10.1002/JMV.25964
DOI	10.1002/JMV.25964
Dimensions Publication ID	wds:Q94530923-9855F705-4791-4D0E-821B-F8E1F3E21BB6
Dimensions Publication ID	1127379626
PMCID	wds:Q94530923-4C4C3100-DB3C-4186-B2D6-5B4957EA2BEB
PMCID	7267594
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q94530923
is cites work of	Preemptive interleukin-6 blockade in patients with COVID-19 Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020 Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment? Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients Nanomedicine strategies to target coronavirus Is there any potential management against COVID-19? A systematic review and meta-analysis Immunity, endothelial injury and complement-induced coagulopathy in COVID-19 Dynamics of coagulopathy in patients with different COVID-19 severity Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role? The role of Interleukin 6 inhibitors in therapy of severe COVID-19 Cardiovascular Considerations in Coronavirus Disease 2019 with a Special Focus on Arrhythmia Association between cytokine profiles and lung injury in COVID-19 pneumonia
is cites work of	wds:Q100504065-B849AEA2-26ED-4FDD-B3AD-6538E50EDDF4 wds:Q96027614-348BBF1A-30BF-4DD1-94D4-263DC354C303 wds:Q97533308-6D64277A-520A-479F-9037-CBA6EA4F11B3 wds:Q103035921-54BB8ED4-7A28-4EB8-8C5E-5A3BFD649820 wds:Q99237635-8BA1FA15-D011-4FF5-90B3-8E8EBE0BCE80 wds:Q99240136-A157EB0A-6C13-43D5-A80C-1D58E3FA7476 wds:Q98565210-DE4F5790-9742-4D14-9021-DF0788DBE6AE wds:Q100737230-D0BD3ADF-0393-4AB0-8617-A7BAC451CD99 wds:Q97426551-F4CAEF9C-8FD3-4AE2-A6BC-43FD221088F9 wds:Q97427143-E7C431B7-0F0D-475A-B00F-A769CE440B7D wds:Q99400656-7A231384-2BA6-476B-980A-7B6877466023 wds:Q98894455-F912B85D-73B7-4168-B1ED-BD9EBA2AE34D wds:Q98181873-8080BD3F-D66E-43D0-B06D-790485298026 wds:Q98163539-0D8C1BD7-DC88-4FE5-895B-EEB0A68EED08

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software